Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
Clinical trial NCT02139358 · COMPLETED
Trial details
- NCT number
- NCT02139358
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-05
- Primary completion
- 2018-04-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.